Kiniksa Pharmaceuticals
KNSA
KNSA
175 hedge funds and large institutions have $888M invested in Kiniksa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
1.23% more ownership
Funds ownership: 93.91% → 95.15% (+1.2%)
6% more call options, than puts
Call options by funds: $2.7M | Put options by funds: $2.55M
4% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 57
Holders
175
Holding in Top 10
2
Calls
$2.7M
Puts
$2.55M
Top Buyers
| 1 | +$33.1M | |
| 2 | +$25.5M | |
| 3 | +$17M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$14.5M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.4M |
Top Sellers
| 1 | -$33.1M | |
| 2 | -$31.3M | |
| 3 | -$24.3M | |
| 4 |
Morgan Stanley
New York
|
-$9.14M |
| 5 |
JPMorgan Chase & Co
New York
|
-$8.03M |
